[1] INABA H,MULLIGHAN C G.Pediatric acute lymphoblastic leukemia[J].Haematologica,2020, 105(11):2524-2539. [2] PELLAND-MARCOTTE M C,HWEE J,POLE J D,et al.Incidence of infections after therapy completion in children with acute lymphoblastic leukemia or acute myeloid leukemia:a systematic review of the literature[J].Leuk Lymphoma,2019,60(9):2104-2114. [3] PUI C H,YANG J J,HUNGER S P,et al.Childhood acute lymphoblastic leukemia:progress through collaboration[J].J Clin Oncol,2015,33(27):2938-2948. [4] O'CONNOR D,BATE J,WADE R,et al.Infection-related mortality in children with acute lymphoblastic leukemia:an analysis of infectious deaths on UKALL2003[J].Blood,2014,124(7):1056-1061. [5] CANIZA M A,ODIO C,MUKKADA S,et al.Infectious complications in children with acute lymphoblastic leukemia treated in low-middle-income countries[J].Expert Rev Hematol,2015,8(5):627-645. [6] 中华医学会儿科学分会血液学组,《中华儿科杂志》编辑委员会.儿童急性淋巴细胞白血病诊疗建议(第四次修订)[J].中华儿科杂志,2014,52(9):641-644. [7] OSKARSSON T, SÖDERHÄLL S, ARVIDSON J,et al.Treatment-related mortality in relapsed childhood acute lymphoblastic leukemia[J].Pediatr Blood Cancer,2018,65(4). [8] HUNGER S P,LU X M,DEVIDAS M,et al.Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005:a report from the children's oncology group[J].J Clin Oncol,2012,30(14):1663-1669. [9] PRUCKER C,ATTARBASCHI A,PETERS C,et al.Induction death and treatment-related mortality in first remission of children with acute lymphoblastic leukemia:a population-based analysis of the Austrian Berlin-Frankfurt-Münster study group[J].Leukemia,2009,23(7):1264-1269. [10] LIU K K,SHAO J B,CAI J Y,et al.Causes of death and treatment-related mortality in newly diagnosed childhood acute lymphoblastic leukemia treatment with Chinese Children's Cancer Group study ALL-2015[J].Ann Hematol,2023,102(12):3431-3444. [11] WEISS S L,PETERS M J,ALHAZZANI W,et al.Executive summary:surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children[J].Intensive Care Med,2020,46(Suppl 1):1-9. [12] 刘畅,付文凤,张姮,等.儿童急性淋巴细胞白血病诱导缓解期并发严重感染的临床分析[J].南京医科大学学报(自然科学版),2023,43(9):1239-1244. [13] 张鹏鹏,王丽娜,李明,等.恶性血液病粒细胞缺乏症患者医院感染的临床特征及危险因素分析[J].中国实验血液学杂志,2020,28(2):669-676. [14] PATEL P A,DEGROOTE N P,JACKSON K,et al.Infectious events in pediatric patients with acute lymphoblastic leukemia/lymphoma undergoing evaluation for fever without severe neutropenia[J].Cancer,2022,128(23):4129-4138. [15] BLASI R D,CATTANEO C,LEWIS R E,et al.Febrile events in acute lymphoblastic leukemia:a prospective observational multicentric SEIFEM study(SEIFEM-2012/B ALL)[J].Ann Hematol,2018,97(5):791-798. [16] 颜莓,唐维兵,黄婕,等.恶性实体瘤儿童营养状况及影响因素研究[J].临床儿科杂志,2021,39(5):327-331. [17] SONOWAL R,GUPTA V.Nutritional status in children with acute lymphoblastic leukemia,and its correlation with severe infection[J].Indian J Cancer,2021,58(2):190-194. [18] INABA H,PEI D,WOLF J,et al.Infection-related complications during treatment for childhood acute lymphoblastic leukemia[J].Ann Oncol,2017,28(2):386-392. [19] WEISS S L,PETERS M J,ALHAZZANI W,et al.Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children[J].Pediatr Crit Care Med,2020,21(2):e52-e106. [20] KUMAR A,ROBERTS D,WOOD K E,et al.Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock[J].Crit Care Med,2006,34(6):1589-1596. [21] KOENIG C,SCHNEIDER C,MORGAN J E,et al.Association of time to antibiotics and clinical outcomes in patients with fever and neutropenia during chemotherapy for cancer:a systematic review[J].Support Care Cancer,2020,28(3):1369-1383. [22] BOROWITZ M J,DEVIDAS M,HUNGER S P,et al.Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors:a Children's Oncology Group study[J].Blood,2008,111(12):5477-5485. |